Search Results - "RABENDA, V"

Refine Results
  1. 1

    Relationship between use of antidepressants and risk of fractures: a meta-analysis by Rabenda, V., Nicolet, D., Beaudart, C., Bruyère, O., Reginster, J.-Y.

    Published in Osteoporosis international (01-01-2013)
    “…Summary It has been shown that antidepressants would have a direct action on bone metabolism and would be associated with increased fracture risk. Results from…”
    Get full text
    Journal Article Web Resource
  2. 2

    Adherence to bisphosphonates therapy and hip fracture risk in osteoporotic women by Rabenda, V., Mertens, R., Fabri, V., Vanoverloop, J., Sumkay, F., Vannecke, C., Deswaef, A., Verpooten, G. A., Reginster, J.-Y.

    Published in Osteoporosis international (01-06-2008)
    “…Summary Adherence is now one of the major issues in the management of osteoporosis and several papers have suggested that vertebral fractures might be…”
    Get full text
    Journal Article Web Resource
  3. 3
  4. 4

    Partial adherence: a new perspective on health economic assessment in osteoporosis by Kanis, J. A., Cooper, C., Hiligsmann, M., Rabenda, V., Reginster, J-Y., Rizzoli, R.

    Published in Osteoporosis international (01-10-2011)
    “…Summary Partial adherence in osteoporosis increases the risk for fragility fracture and has considerable impact on cost-effectiveness. This review highlights a…”
    Get full text
    Journal Article Web Resource
  5. 5

    Adherence, patient preference and dosing frequency: Understanding the relationship by Reginster, J.Y., Rabenda, V., Neuprez, A.

    Published in Bone (New York, N.Y.) (01-04-2006)
    “…Adherence to treatment among patients with chronic diseases is currently suboptimal. Poor adherence leads to reduced clinical benefit, a raised incidence of…”
    Get full text
    Journal Article Web Resource
  6. 6

    Time dependent risk of gastrointestinal complications induced by non-steroidal anti-inflammatory drug use: a consensus statement using a meta-analytic approach by Richy, F, Bruyere, O, Ethgen, O, Rabenda, V, Bouvenot, G, Audran, M, Herrero-Beaumont, G, Moore, A, Eliakim, R, Haim, M, Reginster, J-Y

    Published in Annals of the Rheumatic Diseases (01-07-2004)
    “…Objectives: To provide an updated document assessing the global, NSAID-specific, and time dependent risk of gastrointestinal (GI) complications through…”
    Get full text
    Journal Article Book Review Web Resource
  7. 7

    Adherence to treatment of osteoporosis : a need for study by LEKKERKERKER, F, KANIS, J. A, HUGHES, N, KAUFMAN, J.-M, KORTE, S, KREUTZ, G, LASLOP, A, MITLAK, B, RABENDA, V, RIZZOLI, R, SANTORA, A, SCHIMMER, R, ALSAYED, N, TSOUDEROS, Y, VIETHEL, P, REGINSTER, J.-Y, BOUVENOT, G, BURLET, N, CAHALL, D, CHINES, A, DELMAS, P, DREISER, R.-L, ETHGEN, D

    Published in Osteoporosis international (01-10-2007)
    “…Adherence to anti-osteoporosis medications is currently low and is associated with poor anti-fracture efficacy. This manuscript reviews the potential design of…”
    Get full text
    Journal Article Web Resource
  8. 8

    Effect of collagen hydrolysate in articular pain: A 6-month randomized, double-blind, placebo controlled study by Bruyère, O, Zegels, B, Leonori, L, Rabenda, V, Janssen, A, Bourges, C, Reginster, J.-Y

    Published in Complementary therapies in medicine (01-06-2012)
    “…Summary Objective Evaluation of the efficacy and safety of a food supplement made of collagen hydrolysate 1200 mg/day versus placebo during 6 months, in…”
    Get full text
    Journal Article Web Resource
  9. 9

    Relationship between bone mineral density changes and risk of fractures among patients receiving calcium with or without vitamin D supplementation: a meta-regression by Rabenda, V, Bruyère, O, Reginster, J.-Y

    Published in Osteoporosis international (01-03-2011)
    “…Summary Surrogate measures of fracture risk, such as effects on bone mineral density, may be of great interest to assess the efficacy of available osteoporosis…”
    Get full text
    Journal Article Web Resource
  10. 10

    Antidepressant medications and osteoporosis by Rizzoli, R, Cooper, C, Reginster, J.-Y, Abrahamsen, B, Adachi, J.D, Brandi, M.L, Bruyère, O, Compston, J, Ducy, P, Ferrari, S, Harvey, N.C, Kanis, J.A, Karsenty, G, Laslop, A, Rabenda, V, Vestergaard, P

    Published in Bone (New York, N.Y.) (01-09-2012)
    “…Abstract Use of antidepressant medications that act on the serotonin system has been linked to detrimental impacts on bone mineral density (BMD), and to…”
    Get full text
    Journal Article Web Resource
  11. 11

    Positive impact of compliance to strontium ranelate on the risk of nonvertebral osteoporotic fractures by Rabenda, V, Reginster, J.-Y

    Published in Osteoporosis international (01-12-2010)
    “…Summary Adherence is now one of the major issues in the management of osteoporosis. This paper relates the relationship existing between adherence to strontium…”
    Get full text
    Journal Article Web Resource
  12. 12

    Flurbiprofen in the symptomatic management of rheumatoid arthritis: a valuable alternative by Richy, F, Rabenda, V, Mawet, A, Reginster, J-Y

    “…The withdrawal of certain cyclooxygenase-2 selective drugs and the availability of over-the-counter non-steroidal anti-inflammatory drugs (NSAIDs) have…”
    Get more information
    Journal Article
  13. 13

    Perception, knowledge, and use by general practitioners of Belgium of a new WHO tool (FRAX®) to assess the 10-year probability of fracture by Bruyère, O., Nicolet, D., Compère, S., Rabenda, V., Jeholet, P., Zegels, B., Maassen, P., Pire, G., Reginster, J. Y.

    Published in Rheumatology international (01-04-2013)
    “…The FRAX ® tool that calculates the 10-year probability of having a fracture has recently been validated for Belgium. Little is known about the perception and…”
    Get full text
    Journal Article Web Resource
  14. 14

    The direct and indirect costs of the chronic management of osteoporosis : a prospective follow-up of 3440 active subjects by RABENDA, V, MANETTE, C, LEMMENS, R, MARIANI, A.-M, STRUVAY, N, REGINSTER, J.-Y

    Published in Osteoporosis international (01-09-2006)
    “…The objective of this study was to estimate the direct and indirect costs attributable to osteoporosis (OP) from a societal and a payer's perspective among…”
    Get full text
    Journal Article Web Resource
  15. 15
  16. 16

    Determinants of gastro-protective drugs co-prescription during treatment with nonselective NSAIDs: a prospective survey of 2197 patients recruited in primary care by Rabenda, V., Burlet, N., Belaiche, J., Raeman, F., Richy, F., Reginster, J.-Y.

    Published in Osteoarthritis and cartilage (01-07-2006)
    “…Our goal was to identify the magnitude of gastro-protective drugs (GPDs) co-prescription and the profile of patients who received GPD co-prescription, during…”
    Get full text
    Journal Article Web Resource
  17. 17

    Practical guidance for patient-centred health research by de Wit, Maarten, Cooper, Cyrus, Reginster, Jean-Yves

    Published in The Lancet (British edition) (16-03-2019)
    “…Patients should be offered the opportunity to consult each other on experience-based views, and to ensure proper representation, inviting at least two patient…”
    Get full text
    Journal Article Web Resource
  18. 18
  19. 19

    Poor quality reporting of the meta-analyses in psychology as assessed using the PRISMA Statement by Leclercq, V, Beaudart, C, Ajamieh, S, Rabenda, V, Tirelli, E, Bruyère, O

    Published in European journal of public health (01-11-2018)
    “…Background: Meta-analyses (MAs) are essential for researchers, clinicians and policy makers to make decisions. Analyses of published MAs suggest that their…”
    Get full text
    Journal Article Web Resource
  20. 20

    The clinical and economic burden of non-adherence with oral bisphosphonates in osteoporotic patients by Hiligsmann, Mickaël, Rabenda, Véronique, Bruyère, Olivier, Reginster, Jean-Yves

    Published in Health policy (Amsterdam) (01-07-2010)
    “…Abstract Objectives This study aims to estimate the clinical and economic burden of non-adherence with oral bisphosphonates in osteoporotic patients and the…”
    Get full text
    Journal Article Web Resource